Mølgaard Anne, Arnau Jose, Lauritzen Conni, Larsen Sine, Petersen Gitte, Pedersen John
Centre for Crystallographic Studies, University of Copenhagen, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark.
Biochem J. 2007 Feb 1;401(3):645-50. doi: 10.1042/BJ20061389.
hDDPI (human dipeptidyl peptidase I) is a lysosomal cysteine protease involved in zymogen activation of granule-associated proteases, including granzymes A and B from cytotoxic T-lymphocytes and natural killer cells, cathepsin G and neutrophil elastase, and mast cell tryptase and chymase. In the present paper, we provide the first crystal structure of an hDPPI-inhibitor complex. The inhibitor Gly-Phe-CHN2 (Gly-Phe-diazomethane) was co-crystallized with hDPPI and the structure was determined at 2.0 A (1 A=0.1 nm) resolution. The structure of the native enzyme was also determined to 2.05 A resolution to resolve apparent discrepancies between the complex structure and the previously published structure of the native enzyme. The new structure of the native enzyme is, within the experimental error, identical with the structure of the enzyme-inhibitor complex presented here. The inhibitor interacts with three subunits of hDPPI, and is covalently bound to Cys234 at the active site. The interaction between the totally conserved Asp1 of hDPPI and the ammonium group of the inhibitor forms an essential interaction that mimics enzyme-substrate interactions. The structure of the inhibitor complex provides an explanation of the substrate specificity of hDPPI, and gives a background for the design of new inhibitors.
人二肽基肽酶I(hDDPI)是一种溶酶体半胱氨酸蛋白酶,参与颗粒相关蛋白酶的酶原激活,包括细胞毒性T淋巴细胞和自然杀伤细胞中的颗粒酶A和B、组织蛋白酶G和中性粒细胞弹性蛋白酶,以及肥大细胞类胰蛋白酶和糜酶。在本文中,我们提供了hDPPI-抑制剂复合物的首个晶体结构。抑制剂甘氨酰-苯丙氨酸-重氮甲烷(Gly-Phe-CHN2)与hDPPI共结晶,并在2.0埃(1埃 = 0.1纳米)分辨率下确定了结构。还以2.05埃分辨率确定了天然酶的结构,以解决复合物结构与先前发表的天然酶结构之间明显的差异。在实验误差范围内,天然酶的新结构与本文呈现的酶-抑制剂复合物结构相同。该抑制剂与hDPPI的三个亚基相互作用,并在活性位点与半胱氨酸234共价结合。hDPPI完全保守的天冬氨酸1与抑制剂铵基团之间的相互作用形成了模拟酶-底物相互作用的关键相互作用。抑制剂复合物的结构解释了hDPPI的底物特异性,并为新抑制剂的设计提供了背景。